Summit Therapeutics (SMMT) Appoints Jeff Huber to its Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/10/2026
- Nasdaq ends sharply higher; chip surge offsets Iran worries
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Applied Materials surges as CEO signals multi-year chip boom
- Oil prices settle 2% lower as economic worries outweigh supply risks
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- Key things to know ahead of SK Hynix’s blockbuster US listing
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- S&P Downgrades Oracle To 'bbb-/A-3'; Outlook Stable
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Citi names top picks in software ahead of Q2 earnings
Summit Therapeutics Appoints Jeff Huber, Transformational Google and GRAIL Executive, to its Board of Directors
June 27, 2024 4:15 PM EDTMIAMI--(BUSINESS WIRE)-- Summit Therapeutics Inc. (NASDAQ: SMMT) (Summit, we, or the Company) today announced that Jeff Huber has been appointed to its Board of Directors, effective immediately.
It is an honor to add Jeff Huber to our excellent, diverse group of board members, stated Robert W. Duggan, Chairman and Chief Executive Officer of Summit. Jeffs executive leadership experience in healthcare and technology and his countless accomplishments evidence his ability to translate whats possible into transformational success. As we seek to change the standard of care for solid tumors based on the potential of... More
